-
Product Insights
Maxwell Solar PV Park
Maxwell Solar PV Park is a solar PV project located in New South Wales, Australia. The project is owned by Malabar Resources Ltd and is developed by EDF Renewables SA. The project is at the permitting stage. Empower your strategies with our Maxwell Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
Maxwell Downs Solar PV Park
Maxwell Downs Solar PV Park is a solar PV project located in New South Wales, Australia. The project is owned and being developed by X-Elio Australia Pty Ltd. The project is at the permitting stage. Empower your strategies with our Maxwell Downs Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Company Insights
Innovation and Patenting activity of Suzhou Maxwell Technologies Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Suzhou Maxwell Technologies Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
Otitis Media – Drugs In Development, 2023
Global Markets Direct’s, ‘Otitis Media - Drugs In Development, 2023’, provides an overview of the Otitis Media pipeline landscape. The report provides comprehensive information on the therapeutics under development for Otitis Media, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Sinusitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Sinusitis - Drugs In Development, 2023’, provides an overview of the Sinusitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sinusitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Rhinosinusitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Rhinosinusitis - Drugs In Development, 2023’, provides an overview of the Rhinosinusitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rhinosinusitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2023
Global Markets Direct’s, ‘Ebolavirus Infections (Ebola Hemorrhagic Fever) - Drugs In Development, 2023’, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ebolavirus Infections (Ebola Hemorrhagic Fever), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Mycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Mycoses - Drugs In Development, 2023’, provides an overview of the Mycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Thematic Analysis
Batteries – Thematic Intelligence
Explore the following trends and insights from the ‘Batteries’ thematic report: Synopsis of the batteries theme and understand its progress over the past decade. Key trends impacting the growth of the theme over the next 12 to 24 months, namely, technology trends, macroeconomic trends, and regulatory trends. Multiple data sets, including patents and M&A trends, to set smart business goals. The report also provides a timeline highlighting milestones in the development of the batteries. Core segments of the value chain, including...
-
Sector Analysis
Battery Energy Storage Market Size, Share and Trends Analysis by Region, Technology, Installed Capacity, Key Players and Forecast to 2027
Explore actionable market insights from the following data in the ‘Battery Energy Storage Market’ report: Analysis of the battery energy storage system market growth with a focus on market value at a global level, split regionally - Asia-Pacific, Americas, Europe, and the Middle East and Africa. Market analysis by key countries, including the US, Chile, China, India, Japan, Australia, the Republic of Korea, Germany, the UK, and France. Market value (up to 2018, up to 2022, and up to 2027)...